Handel Johnson & Johnson - JNJ CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.30 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.024874% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.002651% | ||||||||
Gebyr natten over, tid | 21:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | USD | ||||||||
Margen | 20% | ||||||||
Aktiebørs | United States of America | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Johnson & Johnson ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Tidligere luk* | 152.95 |
Åben* | 153.05 |
1-Års Ændring* | -13.33% |
Dagens Spænd* | 152.75 - 153.63 |
52-Ugers Spænd | 150.11-186.69 |
Gennemsnitlig Volumen (10 dage) | 8.70M |
Gennemsnitlig Volumen (3 måneder) | 166.76M |
Market Cap | 473.65B |
P/E-forhold | 22.53 |
Udestående aktier | 3.12B |
Omsætning | 94.94B |
EPS | 6.74 |
Dividend (Udbytte %) | 2.97721 |
Beta | 0.53 |
Næste indtjeningsopgørelse | Apr 18, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Mar 29, 2023 | 152.95 | 0.81 | 0.53% | 152.14 | 153.35 | 151.69 |
Mar 28, 2023 | 151.61 | -1.87 | -1.22% | 153.48 | 153.59 | 151.56 |
Mar 27, 2023 | 153.15 | 0.62 | 0.41% | 152.53 | 154.37 | 152.26 |
Mar 24, 2023 | 152.36 | 1.50 | 0.99% | 150.86 | 152.61 | 150.26 |
Mar 23, 2023 | 151.16 | -0.14 | -0.09% | 151.30 | 151.86 | 149.98 |
Mar 22, 2023 | 151.07 | -2.31 | -1.51% | 153.38 | 154.35 | 150.86 |
Mar 21, 2023 | 153.25 | -0.50 | -0.33% | 153.75 | 154.84 | 152.02 |
Mar 20, 2023 | 153.48 | 2.23 | 1.47% | 151.25 | 153.91 | 151.25 |
Mar 17, 2023 | 152.39 | -1.63 | -1.06% | 154.02 | 154.76 | 152.09 |
Mar 16, 2023 | 153.71 | -0.67 | -0.43% | 154.38 | 154.56 | 152.46 |
Mar 15, 2023 | 153.97 | 0.42 | 0.27% | 153.55 | 154.71 | 151.94 |
Mar 14, 2023 | 153.11 | -1.36 | -0.88% | 154.47 | 155.15 | 151.73 |
Mar 13, 2023 | 154.10 | 1.61 | 1.06% | 152.49 | 155.74 | 150.92 |
Mar 10, 2023 | 151.38 | 0.37 | 0.25% | 151.01 | 153.33 | 150.36 |
Mar 9, 2023 | 151.01 | -1.61 | -1.05% | 152.62 | 153.41 | 150.55 |
Mar 8, 2023 | 152.36 | -1.59 | -1.03% | 153.95 | 154.64 | 152.32 |
Mar 7, 2023 | 153.95 | -1.75 | -1.12% | 155.70 | 156.35 | 153.19 |
Mar 6, 2023 | 155.55 | 1.59 | 1.03% | 153.96 | 155.56 | 153.96 |
Mar 3, 2023 | 153.84 | 1.76 | 1.16% | 152.08 | 153.96 | 151.56 |
Mar 2, 2023 | 152.07 | -0.09 | -0.06% | 152.16 | 152.61 | 151.07 |
Johnson & Johnson Events
Tid (UTC) (UTC) | Land | Begivenhed |
---|---|---|
Monday, April 17, 2023 | ||
Tid (UTC) (UTC) 12:30 | Land US
| Begivenhed Q1 2023 Johnson & Johnson Earnings Release Q1 2023 Johnson & Johnson Earnings ReleaseForecast -Previous - |
Friday, April 28, 2023 | ||
Tid (UTC) (UTC) 14:00 | Land US
| Begivenhed Johnson & Johnson Annual Shareholders Meeting Johnson & Johnson Annual Shareholders MeetingForecast -Previous - |
- Årlig
- Pr kvartal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total omsætning | 94943 | 93775 | 82584 | 82059 | 81581 |
Omsætning | 94943 | 93775 | 82584 | 82059 | 81581 |
Kost af omsætning, Total | 30989 | 29855 | 28327 | 27456 | 26986 |
Bruttofortjeneste | 63954 | 63920 | 54257 | 54603 | 54595 |
Totale Driftsudgifter | 73218 | 70999 | 66087 | 64731 | 63582 |
Salgs/Generelle/Admin. Udgifter, Total | 24765 | 24659 | 22084 | 22178 | 22540 |
Forskning & Udvikling | 14603 | 14714 | 12159 | 11355 | 10775 |
Renteudgift (Indkomst) - Netto Drift | 814 | -370 | -410 | -183 | 394 |
Usædvanlig Udgift (Indkomst) | 5004 | 4041 | 4428 | 1456 | 1826 |
Other Operating Expenses, Total | -2957 | -1900 | -501 | 2469 | 1061 |
Driftsindtægter | 21725 | 22776 | 16497 | 17328 | 17999 |
Netto Indkomst Før Skat | 21725 | 22776 | 16497 | 17328 | 17999 |
Netto Indkomst Efter Skat | 17941 | 20878 | 14414 | 15119 | 15297 |
Netto Indkomst Før Ekstra Ting | 17941 | 20878 | 14414 | 15119 | 15297 |
Netto Indkomst | 17941 | 20878 | 14714 | 15119 | 15297 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 17941 | 20878 | 14414 | 15119 | 15297 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 17941 | 20878 | 14714 | 15119 | 15297 |
Fortyndet Netto Indkomst | 17941 | 20878 | 14714 | 15119 | 15297 |
Fortyndet Vægtet Gennemsnit Aktier | 2663.9 | 2674 | 2670.7 | 2684.3 | 2728.7 |
Fortyndet EPS Uden Ekstraordinære Ting | 6.73486 | 7.80778 | 5.39709 | 5.63238 | 5.60597 |
Dividends per Share - Common Stock Primary Issue | 4.45 | 4.19 | 3.98 | 3.75 | 3.54 |
Fortyndet Normaliseret EPS | 8.67833 | 9.22111 | 6.98515 | 7.87 | 6.92185 |
Totale Ekstraordinære Ting | 300 |
Jan 2023 | Oct 2022 | Jul 2022 | Apr 2022 | Jan 2022 | |
---|---|---|---|---|---|
Total omsætning | 23706 | 23791 | 24020 | 23426 | 24804 |
Omsætning | 23706 | 23791 | 24020 | 23426 | 24804 |
Kost af omsætning, Total | 7711 | 7794 | 7902 | 7582 | 7955 |
Bruttofortjeneste | 15995 | 15997 | 16118 | 15844 | 16849 |
Totale Driftsudgifter | 19505 | 17969 | 18180 | 17564 | 19968 |
Salgs/Generelle/Admin. Udgifter, Total | 6512 | 6089 | 6226 | 5938 | 7154 |
Forskning & Udvikling | 3841 | 3597 | 3703 | 3462 | 4720 |
Renteudgift (Indkomst) - Netto Drift | -77 | 101 | 74 | 388 | -153 |
Usædvanlig Udgift (Indkomst) | 1871.2 | 723 | 828 | 1382 | 1234 |
Other Operating Expenses, Total | -353.2 | -335 | -553 | -1188 | -942 |
Driftsindtægter | 4201 | 5822 | 5840 | 5862 | 4836 |
Netto Indkomst Før Skat | 4201 | 5822 | 5840 | 5862 | 4836 |
Netto Indkomst Efter Skat | 3520 | 4458 | 4814 | 5149 | 4736 |
Netto Indkomst Før Ekstra Ting | 3520 | 4458 | 4814 | 5149 | 4736 |
Netto Indkomst | 3520 | 4458 | 4814 | 5149 | 4736 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 3520 | 4458 | 4814 | 5149 | 4736 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 3520 | 4458 | 4814 | 5149 | 4736 |
Fortyndet Netto Indkomst | 3520 | 4458 | 4814 | 5149 | 4736 |
Fortyndet Vægtet Gennemsnit Aktier | 2653.1 | 2661.3 | 2667.9 | 2666.5 | 2672.2 |
Fortyndet EPS Uden Ekstraordinære Ting | 1.32675 | 1.67512 | 1.80442 | 1.931 | 1.77232 |
Dividends per Share - Common Stock Primary Issue | 1.13 | 1.13 | 1.13 | 1.06 | 1.06 |
Fortyndet Normaliseret EPS | 2.02302 | 1.94069 | 2.12204 | 2.41406 | 2.22457 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 60979 | 51237 | 45274 | 46033 | 43088 |
Likvider og Kortsigtede Investeringer | 31608 | 25185 | 19287 | 19687 | 18296 |
Cash | 2936 | 2863 | 2637 | 2619 | 2929 |
Likvider & Lignende | 1901 | 2102 | 2864 | 3397 | 4288 |
Kortsigtede Investeringer | 26771 | 20220 | 13786 | 13671 | 11079 |
Totale Tilgodehavender, Netto | 15283 | 13576 | 14481 | 14098 | 13490 |
Accounts Receivable - Trade, Net | 15283 | 13576 | 14481 | 14098 | 13490 |
Total Inventory | 10387 | 9344 | 9020 | 8599 | 8765 |
Prepaid Expenses | 3701 | 3132 | 2392 | 2699 | 2537 |
Total Assets | 182018 | 174894 | 157728 | 152954 | 157303 |
Property/Plant/Equipment, Total - Net | 19862 | 19766 | 18615 | 17035 | 17005 |
Property/Plant/Equipment, Total - Gross | 48579 | 47804 | 44289 | 41851 | 41466 |
Accumulated Depreciation, Total | -28717 | -28038 | -25674 | -24816 | -24461 |
Goodwill, Net | 35246 | 36393 | 33639 | 30453 | 31906 |
Intangibles, Net | 46392 | 53402 | 47643 | 47611 | 53228 |
Other Long Term Assets, Total | 17655 | 12615 | 11409 | 11311 | 12076 |
Total Current Liabilities | 45226 | 42493 | 35964 | 31230 | 30537 |
Accounts Payable | 11055 | 9505 | 7537 | 7310 | |
Accrued Expenses | 29293 | 28965 | 32496 | 20079 | 17467 |
Notes Payable/Short Term Debt | 1635 | 832 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 2131 | 1799 | 1202 | 2297 | 3906 |
Other Current Liabilities, Total | 1112 | 1392 | 2266 | 1317 | 1854 |
Total Liabilities | 107995 | 111616 | 98257 | 93202 | 97143 |
Total Long Term Debt | 29985 | 32635 | 26494 | 27684 | 30675 |
Long Term Debt | 29985 | 32635 | 26494 | 27684 | 30675 |
Deferred Income Tax | 7487 | 7214 | 5958 | 7506 | 8368 |
Other Liabilities, Total | 25297 | 29274 | 29841 | 26782 | 27563 |
Total Equity | 74023 | 63278 | 59471 | 59752 | 60160 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 3120 | 3120 | 3120 | 3120 | 3120 |
Retained Earnings (Accumulated Deficit) | 123060 | 113890 | 110659 | 106216 | 101793 |
Treasury Stock - Common | -39099 | -38490 | -38417 | -34362 | -31554 |
Unrealized Gain (Loss) | -3 | 1 | 0 | 0 | 232 |
Other Equity, Total | -13055 | -15243 | -15891 | -15222 | -13431 |
Total Liabilities & Shareholders’ Equity | 182018 | 174894 | 157728 | 152954 | 157303 |
Total Common Shares Outstanding | 2628.97 | 2632.51 | 2632.51 | 2662.32 | 2682.52 |
Other Current Assets, Total | 0 | 94 | 950 | ||
Long Term Investments | 1884 | 1481 | 1148 | 511 |
Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 60424 | 60979 | 59889 | 53769 | 52533 |
Likvider og Kortsigtede Investeringer | 30388 | 31608 | 31001 | 25306 | 24619 |
Cash | 3128 | 2936 | 2607 | 2313 | 2247 |
Likvider & Lignende | 1579 | 1901 | 2120 | 2618 | 2094 |
Kortsigtede Investeringer | 25681 | 26771 | 26274 | 20375 | 20278 |
Totale Tilgodehavender, Netto | 15594 | 15283 | 14911 | 14871 | 14938 |
Accounts Receivable - Trade, Net | 15594 | 15283 | 14911 | 14871 | 14938 |
Total Inventory | 10990 | 10387 | 10387 | 10100 | 9952 |
Prepaid Expenses | 3452 | 3701 | 3590 | 3492 | 3024 |
Total Assets | 178355 | 182018 | 179228 | 176440 | 172557 |
Property/Plant/Equipment, Total - Net | 18701 | 19862 | 18478 | 18632 | 18367 |
Property/Plant/Equipment, Total - Gross | 47702 | 47679 | 47347 | 47201 | 46430 |
Accumulated Depreciation, Total | -29001 | -28717 | -28869 | -28569 | -28063 |
Goodwill, Net | 34935 | 35246 | 35569 | 35819 | 35688 |
Intangibles, Net | 44420 | 46392 | 47776 | 50244 | 51110 |
Long Term Investments | 1452 | 1884 | 1867 | 1678 | 1452 |
Other Long Term Assets, Total | 18423 | 17655 | 15649 | 16298 | 13407 |
Total Current Liabilities | 43390 | 45226 | 44561 | 38721 | 40932 |
Accounts Payable | 9309 | 11055 | 8961 | 8704 | 8503 |
Accrued Expenses | 28076 | 29293 | 29641 | 25644 | 27202 |
Notes Payable/Short Term Debt | 3800 | 1635 | 1300 | 600 | 300 |
Current Port. of LT Debt/Capital Leases | 497 | 2131 | 2498 | 2573 | 3050 |
Other Current Liabilities, Total | 1708 | 1112 | 2161 | 1200 | 1877 |
Total Liabilities | 103646 | 107995 | 108956 | 106860 | 106723 |
Total Long Term Debt | 28851 | 29985 | 30130 | 30310 | 30263 |
Long Term Debt | 28851 | 29985 | 30130 | 30310 | 30263 |
Deferred Income Tax | 6424 | 7487 | 7147 | 9016 | 6507 |
Other Liabilities, Total | 24981 | 25297 | 27118 | 28813 | 29021 |
Total Equity | 74709 | 74023 | 70272 | 69580 | 65834 |
Common Stock | 3120 | 3120 | 3120 | 3120 | 3120 |
Retained Earnings (Accumulated Deficit) | 124380 | 123060 | 121092 | 120154 | 116508 |
Treasury Stock - Common | -39034 | -39099 | -38525 | -38594 | -38466 |
Unrealized Gain (Loss) | -16 | -3 | 0 | 0 | 1 |
Other Equity, Total | -13741 | -13055 | -15415 | -15100 | -15329 |
Total Liabilities & Shareholders’ Equity | 178355 | 182018 | 179228 | 176440 | 172557 |
Total Common Shares Outstanding | 2629.38 | 2628.97 | 2632.49 | 2631.99 | 2632.7 |
Preferred Stock - Non Redeemable, Net | 0 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netto indkomst/Startlinje | 20878 | 14714 | 15119 | 15297 | 1300 |
Likvider Fra Driftsaktiviteter | 23410 | 23536 | 23416 | 22201 | 21056 |
Likvider Fra Driftsaktiviteter | 7390 | 7231 | 7009 | 6929 | 5642 |
Deferred Taxes | -2079 | -1141 | -2476 | -1016 | 2406 |
Ikke-Likvide Ting | 1459 | 42 | -101 | 988 | 467 |
Cash Taxes Paid | 4768 | 4619 | 4191 | 4570 | 3312 |
Likvid Rente Betalt | 990 | 904 | 995 | 1049 | 960 |
Ændringer i Driftskapital | -4238 | 2690 | 3865 | 3 | 11241 |
Likvider fra Investeringsaktiviteter | -8683 | -20825 | -6194 | -3167 | -14868 |
Kapitaludgifter | -3652 | -3347 | -3498 | -3670 | -3279 |
Andre Investerings-Cash-Flow-Ting, Total | -5031 | -17478 | -2696 | 503 | -11589 |
Likvider fra Financieringsaktiviteter | -14047 | -6120 | -18015 | -18510 | -7673 |
Financiering af Cash-Flow-Ting | 395 | -627 | 575 | -148 | -188 |
Total Cash Dividends Paid | -11032 | -10481 | -9917 | -9494 | -8943 |
Udstedelse (Pensionering) af Aktier, Netto | -2420 | -2107 | -5792 | -4919 | -5296 |
Udstedelse (Pensionering) af Gæld, Netto | -990 | 7095 | -2881 | -3949 | 6754 |
Udenlandsk Børs Effekter | -178 | 89 | -9 | -241 | 337 |
Netto Ændring i Likviditet | 502 | -3320 | -802 | 283 | -1148 |
Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 5149 | 20878 | 16142 | 12475 | 6197 |
Cash From Operating Activities | 3979 | 23410 | 17678 | 9388 | 4074 |
Cash From Operating Activities | 1769 | 7390 | 5547 | 3733 | 1894 |
Deferred Taxes | -926 | -2079 | -2564 | -685 | -730 |
Non-Cash Items | 726 | 1459 | 1223 | 34 | -272 |
Changes in Working Capital | -2739 | -4238 | -2670 | -6169 | -3015 |
Cash From Investing Activities | -3634 | -8683 | -3323 | -604 | -185 |
Capital Expenditures | -607 | -3652 | -2237 | -1490 | -677 |
Other Investing Cash Flow Items, Total | -3027 | -5031 | -1086 | 886 | 492 |
Cash From Financing Activities | -4385 | -14047 | -10611 | -8404 | -5125 |
Financing Cash Flow Items | -373 | 395 | 269 | 213 | 188 |
Total Cash Dividends Paid | -2787 | -11032 | -8241 | -5450 | -2659 |
Issuance (Retirement) of Stock, Net | -1256 | -2420 | -1652 | -1526 | -1202 |
Issuance (Retirement) of Debt, Net | 31 | -990 | -987 | -1641 | -1452 |
Foreign Exchange Effects | 16 | -178 | -125 | -33 | -78 |
Net Change in Cash | -4024 | 502 | 3619 | 347 | -1314 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.8771 | 245753287 | 1454228 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.5542 | 142084378 | 198067 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.0211 | 125452825 | -986275 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.5372 | 47958583 | 294671 | 2022-12-31 | LOW |
State Farm Insurance Companies | Insurance Company | 1.0153 | 31675492 | 0 | 2022-12-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 0.861 | 26861119 | -1125820 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8364 | 26093398 | 1700287 | 2022-12-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 0.8236 | 25695612 | 3814698 | 2022-12-31 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.7267 | 22671643 | 204861 | 2022-12-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7015 | 21884954 | 24625 | 2022-12-31 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 0.6562 | 20472848 | -1558866 | 2022-12-31 | LOW |
BofA Global Research (US) | Research Firm | 0.6347 | 19800227 | -625991 | 2022-12-31 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.5901 | 18410390 | -654505 | 2022-12-31 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.5892 | 18382540 | 418336 | 2022-12-31 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 0.586 | 18280864 | 141119 | 2022-12-31 | LOW |
Capital International Investors | Investment Advisor | 0.5632 | 17569654 | -1212751 | 2022-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.5477 | 17086571 | 174516 | 2022-12-31 | LOW |
Wells Fargo Advisors | Research Firm | 0.5436 | 16958793 | 47687 | 2022-12-31 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.532 | 16596744 | -2192644 | 2022-12-31 | LOW |
BlackRock Asset Management Ireland Limited | Investment Advisor | 0.4993 | 15576114 | -481392 | 2022-12-31 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Johnson & Johnson Company profile
Om Johnson & Johnson
Johnson & Johnson er et holdingselskab, der beskæftiger sig med forskning og udvikling, fremstilling og salg af en række produkter inden for sundhedssektoren. Virksomheden opererer gennem tre segmenter: Consumer Health, Pharmaceutical og Medical Devices. Virksomhedens primære fokus er produkter i forbindelse med menneskers sundhed og velvære. Consumer Health-segmentet omfatter en række produkter, der er fokuseret på personlig sundhedspleje inden for hudpleje/skønhedspleje, håndkøbsmedicin, babypleje, mundpleje, kvindesundhed og sårpleje. Farmaceutisk segment er fokuseret på seks terapeutiske områder: Immunologi, infektionssygdomme, neurovidenskab, onkologi, kardiovaskulære sygdomme, metabolisme og pulmonal hypertension. Segmentet Medicinsk udstyr omfatter en række produkter, der anvendes inden for interventionsløsninger, ortopædkirurgi, kirurgi og synsområdet. Det geografiske område omfatter USA, Europa, den vestlige halvkugle (undtagen USA) og Afrika, Asien og Stillehavsområdet.
Industry: | Pharmaceuticals (NEC) |
One Johnson & Johnson Plaza
NEW BRUNSWICK
NEW JERSEY 08933
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com